Diabetes drug could be new hope for failing hearts in lung disease
Disease control
ENROLLING_BY_INVITATION
This study is testing if a medication called empagliflozin, already used for diabetes and heart failure, can help improve heart function in people with pulmonary arterial hypertension (PAH). About 78 adults with PAH who are already on stable treatment will take either the drug or…
Phase: PHASE2 • Sponsor: Gustavo A Heresi, MD, MS • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC